ANIP ANI Pharmaceuticals, Inc. Stock Quote

ANIP [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-4.52	Insider Own	5.40%	Shs Outstand	16.14M	Perf Week	2.19%
Market Cap	498.59M	Forward P/E	9.91	EPS next Y	3.01	Insider Trans	4.49%	Shs Float	12.79M	Perf Month	-3.53%
Income	-63.40M	PEG	-	EPS next Q	0.24	Inst Own	73.40%	Short Float	5.00%	Perf Quarter	-18.19%
Sales	226.10M	P/S	2.21	EPS this Y	-80.30%	Inst Trans	2.93%	Short Ratio	4.30	Perf Half Y	-33.75%
Book/sh	19.91	P/B	1.50	EPS next Y	118.12%	ROA	-10.30%	Target Price	40.67	Perf Year	-11.49%
Cash/sh	4.60	P/C	6.48	EPS next 5Y	2.20%	ROE	-24.40%	52W Range	22.73 - 60.23	Perf YTD	-35.29%
Dividend	-	P/FCF	-	EPS past 5Y	-64.40%	ROI	-4.20%	52W High	-50.49%	Beta	1.03
Dividend %	-	Quick Ratio	2.70	Sales past 5Y	10.90%	Gross Margin	49.20%	52W Low	31.19%	ATR	1.85
Employees	601	Current Ratio	3.80	Sales Q/Q	18.30%	Oper. Margin	-27.40%	RSI (14)	52.25	Volatility	6.30% 6.99%
Optionable	Yes	Debt/Eq	0.89	EPS Q/Q	-	Profit Margin	-28.00%	Rel Volume	0.94	Prev Close	28.71
Shortable	Yes	LT Debt/Eq	0.89	Earnings	May 10 BMO	Payout	-	Avg Volume	148.66K	Price	29.82
Recom	2.30	SMA20	4.71%	SMA50	2.32%	SMA200	-17.69%	Volume	139,979	Change	3.87%

Nov-02-21

Initiated

Truist

Buy

$70

May-07-20

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Sep-12-19

Initiated

Guggenheim

Buy

May-10-19

Downgrade

Raymond James

Strong Buy → Outperform

$73 → $82

Oct-16-17

Reiterated

Canaccord Genuity

Buy

$60 → $66

Jul-31-17

Initiated

Canaccord Genuity

Buy

$60

Feb-22-17

Downgrade

ROTH Capital

Buy → Neutral

Jun-23-16

Initiated

Raymond James

Strong Buy

$68

May-24-16

Downgrade

Standpoint Research

Buy → Hold

Nov-13-15

Initiated

Standpoint Research

Buy

$54

Sep-28-15

Upgrade

ROTH Capital

Neutral → Buy

$67 → $60

Aug-05-15

Reiterated

Oppenheimer

Outperform

$74 → $65

Aug-04-15

Reiterated

ROTH Capital

Neutral

$70 → $67

Jul-31-15

Reiterated

Oppenheimer

Outperform

$72 → $74

Jul-15-15

Reiterated

ROTH Capital

Neutral

$60 → $70

Jun-23-15

Reiterated

Oppenheimer

Outperform

$61 → $67

May-18-15

Reiterated

ROTH Capital

Neutral

$78 → $60

May-06-15

Reiterated

Oppenheimer

Outperform

$69 → $61

Apr-10-15

Downgrade

ROTH Capital

Buy → Neutral

$78

Feb-26-15

Reiterated

ROTH Capital

Buy

$65 → $78

May-20-22 06:50AM	ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences Business Wire
May-10-22 08:05AM	ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:50AM	ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million Business Wire
May-09-22 09:15AM	Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates Zacks
May-05-22 08:55AM	Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates Zacks
Apr-19-22 06:50AM	ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022 Business Wire +5.74%
Apr-11-22 06:50AM	ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets Business Wire
Mar-24-22 11:46AM	Insider Buying: The ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Chairman Just Bought 10% More Shares Simply Wall St.
Mar-22-22 04:05PM	ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors Business Wire
Mar-17-22 03:00PM	11 Stocks Making Headlines After Earnings Reports Insider Monkey +5.26%
Mar-15-22 09:15AM	ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates Zacks -18.65%
08:59AM	ANI Pharmaceuticals Down 25% After Earnings Miss Investing.com
06:50AM	ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth Business Wire
Mar-07-22 06:50AM	ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022 Business Wire
Mar-02-22 04:49AM	Here's What ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Shareholder Ownership Structure Looks Like Simply Wall St.
Mar-01-22 05:15PM	Cara Therapeutics (CARA) Reports Q4 Loss, Lags Revenue Estimates Zacks
Feb-24-22 06:50AM	ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team Business Wire
Feb-23-22 05:25PM	BioMarin Pharmaceutical (BMRN) Q4 Earnings and Revenues Top Estimates Zacks
Feb-14-22 05:00PM	Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) Powder, Including 180 Days of Exclusivity PR Newswire
Jan-31-22 09:38PM	High Note Wealth, LLC Buys The Walt Disney Co, Uber Technologies Inc, Block Inc, Sells ... GuruFocus.com
Jan-24-22 06:50AM	ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders Business Wire
Jan-03-22 04:30PM	ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference Business Wire
Dec-21-21 06:50AM	ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP Business Wire
Dec-20-21 07:30AM	Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid) GlobeNewswire
Dec-16-21 09:53AM	7 of the Best Small-Cap Stocks to Buy Before 2022 InvestorPlace
Nov-22-21 06:50AM	ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses Business Wire
06:40AM	ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 Business Wire
Nov-11-21 06:50AM	ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma Business Wire
Nov-10-21 04:04PM	U.S. FTC approves ANI deal to buy Novitium, with conditions Reuters -5.50%
Nov-08-21 04:05PM	ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock Business Wire
Nov-03-21 10:54PM	ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock Business Wire
04:03PM	ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock Business Wire
Nov-02-21 06:55AM	Insiders who bought ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) last year must be regretting not buying more as market cap hits US$677m Simply Wall St.
Nov-01-21 09:00PM	ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript Motley Fool +49.52%
04:07PM	Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug Investor's Business Daily
02:33PM	Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide Benzinga
12:36PM	Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today Motley Fool
12:14PM	Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump Benzinga
12:05PM	40 Stocks Moving In Monday's Mid-Day Session Benzinga
10:35AM	Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views Benzinga
08:05AM	ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates Zacks
06:45AM	ANI Pharmaceuticals Reports Third Quarter 2021 Results Business Wire
06:30AM	ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome Business Wire
Oct-29-21 04:30PM	ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021 Business Wire
Oct-28-21 03:05PM	Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-01-21 01:10PM	7 Overbought Stocks to Be Very Careful of Right Now InvestorPlace
Sep-20-21 04:30PM	ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021 Business Wire
Sep-17-21 06:50AM	ANI Pharmaceuticals Announces Launch of Nebivolol Tablets Business Wire
Sep-03-21 07:12AM	Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Aug-31-21 06:50AM	ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome Business Wire +10.69%
Aug-06-21 02:31PM	ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript Motley Fool
08:45AM	ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates Zacks
07:24AM	ANI Pharmaceuticals Reports Second Quarter 2021 Results Business Wire
Jul-30-21 03:00PM	Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-21 04:30PM	ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021 Business Wire
Jul-06-21 06:50AM	ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA Business Wire
Jul-05-21 01:46AM	ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 51% On Their Shares Simply Wall St.
Jun-30-21 09:26AM	ANI Pharmaceuticals Inc (ANIP) Fell Out Of Favor With Hedge Funds Insider Monkey +5.80%
Jun-15-21 04:05PM	ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021 Business Wire
Jun-01-21 04:05PM	ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders Business Wire
May-27-21 04:30PM	ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021 Business Wire
May-24-21 09:06AM	New Strong Sell Stocks for May 24th Zacks
May-07-21 11:30AM	ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript Motley Fool +10.29%
08:05AM	ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Top Estimates Zacks
06:50AM	ANI Pharmaceuticals Reports First Quarter 2021 Results Business Wire
06:45AM	ANI Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Apr-30-21 03:00PM	Earnings Preview: ANI Pharmaceuticals (ANIP) Q1 Earnings Expected to Decline Zacks
Apr-27-21 01:41PM	ANI Pharmaceuticals, Inc. -- Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stable Moody's
01:24PM	ANI Pharmaceuticals, Inc. -- Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stable Moody's
Apr-26-21 04:30PM	ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021 Business Wire
Apr-06-21 06:50AM	ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs Business Wire
Mar-22-21 06:27AM	ANI Pharmaceuticals (ANIP) Enters Overbought Territory Zacks
Mar-09-21 01:00PM	ANI Pharmaceuticals Inc (ANIP) Q4 2020 Earnings Call Transcript Motley Fool
08:05AM	ANI Pharmaceuticals (ANIP) Q4 Earnings Miss Estimates Zacks
06:50AM	ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth Business Wire
06:45AM	ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business Business Wire
05:30AM	ANI Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-08-21 10:18AM	ANI Pharmaceuticals's Earnings: A Preview Benzinga
Mar-07-21 01:25AM	What Type Of Shareholders Make Up ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Share Registry? Simply Wall St.
Mar-02-21 12:30PM	Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline Zacks
Feb-19-21 04:30PM	ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Feb-17-21 06:50AM	ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth Business Wire
Feb-16-21 04:30PM	ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021 Business Wire
Feb-01-21 06:50AM	ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride ("HCl") Capsules Business Wire
Jan-06-21 12:13AM	ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 54% On Their Shares Simply Wall St.
Dec-17-20 06:50AM	ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets Business Wire
Dec-03-20 09:50PM	Is ANI Pharmaceuticals (ANIP) A Good Stock To Buy Now? Insider Monkey
Nov-17-20 10:32AM	Should Value Investors Pick ANI Pharmaceuticals (ANIP) Now? Zacks
Nov-07-20 07:44AM	Should You Take Comfort From Insider Transactions At ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)? Simply Wall St.
Nov-05-20 04:01PM	ANI Pharmaceuticals Inc (ANIP) Q3 2020 Earnings Call Transcript Motley Fool -5.36%
06:50AM	ANI Pharmaceuticals Reports Third Quarter 2020 Results Business Wire
Oct-29-20 06:50AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results Business Wire
Oct-28-20 12:32PM	Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for Zacks
Sep-10-20 07:00PM	ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-06-20 08:35AM	ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates Zacks
06:50AM	ANI Pharmaceuticals Reports Second Quarter 2020 Results Business Wire
06:45AM	ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors Business Wire
Aug-03-20 06:50AM	ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer Business Wire
Jul-30-20 06:50AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results Business Wire
Jul-29-20 12:33PM	Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to Decline Zacks

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lalwani Nikhil	PRESIDENT & CEO	Mar 21	Buy	27.69	7,224	199,997	169,650	Mar 23 09:05 PM
Walsh Patrick D	Director	Mar 21	Buy	27.76	5,000	138,794	53,388	Mar 22 05:39 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Mar 21	Buy	27.87	5,000	139,342	393,226	Mar 22 05:37 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Mar 18	Buy	27.15	5,000	135,744	388,226	Mar 22 05:37 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Mar 17	Buy	27.65	5,000	138,252	5,000	Mar 21 09:58 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Mar 17	Buy	27.65	5,000	138,252	18,460	Mar 21 09:58 PM
Thoma Jeanne	Director	Dec 20	Buy	46.47	1,072	49,820	17,785	Dec 22 08:06 PM
Pera Antonio R	Director	Dec 07	Buy	42.26	3,000	126,794	19,713	Dec 09 04:31 PM
HAUGHEY THOMAS	Director	Dec 06	Buy	39.38	2,500	98,450	30,202	Dec 07 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience